CMND

Clearmind Medicine Inc. - Common Shares (CMND)

About Clearmind Medicine Inc. - Common Shares (CMND)

Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. It focuses on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize it as regulated medicines, foods, or supplements. The company was founded on July 18, 2017 and is headquartered in Vancouver, Canada.

Details

Daily high
$1.59
Daily low
$1.31
Price at open
$1.48
52 Week High
$58.00
52 Week Low
$1.31
Market cap
107,000
Dividend yield
0.00%
Volume
2.5M
Avg. volume
507,222
P/E ratio
-.04

Clearmind Medicine Inc. - Common Shares News

Details

Daily high
$1.59
Daily low
$1.31
Price at open
$1.48
52 Week High
$58.00
52 Week Low
$1.31
Market cap
107,000
Dividend yield
0.00%
Volume
2.5M
Avg. volume
507,222
P/E ratio
-.04